Your browser doesn't support javascript.
loading
Treatment Preferences in Young Adults with Moderate to Severe Psoriasis: A Qualitative Study from the Nordic Countries.
Balieva, Flora Nicol; Catton, Louise; Claréus, Birgitta W; Danielsen, Kjersti; Fierens, Frederik; Iversen, Lars; Koulu, Leena; Osmanecevic, Amra; Pasternack, Rafael; Skov, Lone.
Afiliação
  • Balieva FN; Department of Dermatology, Stavanger University Hospital, Cort Adelersgate 12, Pb. 8100, 4068, Stavanger, Norway. florabalieva@gmail.com.
  • Catton L; Department of Public Health, Faculty of Health Sciences, University of Stavanger, Stavanger, Norway. florabalieva@gmail.com.
  • Claréus BW; UCB Pharma, Brussels, Belgium.
  • Danielsen K; Psoriasis Association Treatment Wards, Stockholm, Sweden.
  • Fierens F; Department of Community Medicine, UiT, The Arctic University of Norway, Tromsø, Norway.
  • Iversen L; UCB Pharma, Brussels, Belgium.
  • Koulu L; Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark.
  • Osmanecevic A; Department of Dermatology, Turku University Hospital and University of Turku, Turku, Finland.
  • Pasternack R; Department of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Skov L; Department of Dermatology and Venereology, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg, Sweden.
Dermatol Ther (Heidelb) ; 13(8): 1873-1887, 2023 Aug.
Article em En | MEDLINE | ID: mdl-37452929
Not much research has been done on understanding the disease burden and treatment needs of young adults suffering from psoriasis. This is an interview study with young adults from Nordic countries suffering from moderate to severe psoriasis with an active lifestyle. The adult patients were all referred for biologic treatment of psoriasis but had not yet started treatment when they were interviewed. The aim was to explore treatment preferences in this group.The study showed that treatment goals depended upon both alleviation of symptoms and obtaining a low treatment burden. The most influential symptoms were scaling, itching, and visible plaques. The most important treatment burden features were efficacy, durability, speed of response, safety, and convenience. Understanding the reasons behind these different treatment preferences is essential to help shared-decision psoriasis management that matches individual needs.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Qualitative_research Aspecto: Patient_preference Idioma: En Revista: Dermatol Ther (Heidelb) Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Qualitative_research Aspecto: Patient_preference Idioma: En Revista: Dermatol Ther (Heidelb) Ano de publicação: 2023 Tipo de documento: Article